Cargando…

CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases

To date, no curative therapy is available for the treatment of most chronic inflammatory diseases such as atopic dermatitis, rheumatoid arthritis, or autoimmune disorders. Current treatments require a lifetime supply for patients to alleviate clinical symptoms and are unable to stop the course of di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akinrinmade, Olusiji A., Chetty, Shivan, Daramola, Adebukola K., Islam, Mukit-ul, Thepen, Theo, Barth, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618314/ https://www.ncbi.nlm.nih.gov/pubmed/28895912 http://dx.doi.org/10.3390/biomedicines5030056

Ejemplares similares

Macrophage-Targeted Therapy: CD64-Based Immunotoxins for Treatment of Chronic Inflammatory Diseases
por: Hristodorov, Dmitrij, et al.
Publicado: (2012)

Human Granzyme B Based Targeted Cytolytic Fusion Proteins
por: Hlongwane, Precious, et al.
Publicado: (2018)

Updates in the Development of ImmunoRNases for the Selective Killing of Tumor Cells
por: Jordaan, Sandra, et al.
Publicado: (2018)

Human MAP Tau Based Targeted Cytolytic Fusion Proteins
por: Akinrinmade, Olusiji A., et al.
Publicado: (2017)

Restoration of DAP Kinase Tumor Suppressor Function: A Therapeutic Strategy to Selectively Induce Apoptosis in Cancer Cells Using Immunokinase Fusion Proteins
por: Tur, Mehmet Kemal, et al.
Publicado: (2017)

CD64-directed microtubule associated protein tau kills leukemic blasts ex vivo
por: Mladenov, Radoslav, et al.
Publicado: (2016)

CD64 as a biomarker and therapeutic target in HAM/TSP and HTLV-1-associated Infective Dermatitis
por: Khouri, Ricardo, et al.
Publicado: (2011)

Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy
por: Dogbey, Dennis Makafui, et al.
Publicado: (2023)

Principles of Immunotherapy: Implications for Treatment Strategies in Cancer and Infectious Diseases
por: Naran, Krupa, et al.
Publicado: (2018)

Using the SNAP-Tag technology to easily measure and demonstrate apoptotic changes in cancer and blood cells with different dyes
por: Woitok, Mira, et al.
Publicado: (2020)

Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
por: Chouari, Tarak, et al.
Publicado: (2023)

Targeted human cytolytic fusion proteins at the cutting edge: harnessing the apoptosis-inducing properties of human enzymes for the selective elimination of tumor cells
por: Mungra, Neelakshi, et al.
Publicado: (2019)

CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis
por: Liu, Shuangqing, et al.
Publicado: (2023)

Macrophages as a Potential Immunotherapeutic Target in Solid Cancers
por: Mishra, Alok K., et al.
Publicado: (2022)

Efficacy of an adapted granzyme B-based anti-CD30 cytolytic fusion protein against PI-9-positive classical Hodgkin lymphoma cells in a murine model
por: Schiffer, S, et al.
Publicado: (2013)

Selective elimination of inflammatory macrophages by Fcγ-RI-directed immunotoxins: a novel concept in the treatment of rheumatoid arthritis
por: van Roon, JAG, et al.
Publicado: (2002)

Elderly CD8(+) T cells in the focus for immunotherapeutic approaches
por: Lis, Annette, et al.
Publicado: (2023)

P25. Access to diagnostics: a bottleneck for immunotherapeutics development - case example of MAGE-A3 cancer immunotherapeutic
por: Lykopoulos, K, et al.
Publicado: (2014)

CSPG4: A Target for Selective Delivery of Human Cytolytic Fusion Proteins and TRAIL
por: Jordaan, Sandra, et al.
Publicado: (2017)

The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
por: Bosmans, Laura A., et al.
Publicado: (2020)

Cancel cancer: The immunotherapeutic potential of CD200/CD200R blockade
por: Choe, Deborah, et al.
Publicado: (2023)

Immunotherapeutic potential of Crotoxin: anti-inflammatory and immunosuppressive properties
por: Sartim, Marco Aurélio, et al.
Publicado: (2018)

Designing the Sniper: Improving Targeted Human Cytolytic Fusion Proteins for Anti-Cancer Therapy via Molecular Simulation
por: Bochicchio, Anna, et al.
Publicado: (2017)

A recombinant Der p 1-specific allergen-toxin demonstrates superior killing of allergen-reactive IgG(+) hybridomas in comparison to its recombinant allergen-drug conjugate
por: Daramola, A K, et al.
Publicado: (2022)

CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
por: Morandi, Fabio, et al.
Publicado: (2018)

The Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell Carcinoma
por: Zhang, Keying, et al.
Publicado: (2021)

Diagnosis of infection utilizing accellix CD64
por: Sprung, CL, et al.
Publicado: (2015)

Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum
por: Schmitz, Veronica, et al.
Publicado: (2016)

In contrast to CD64 expression, CD14 expression is persistently downregulated on polymorphonuclear cells (PMN) but not on monocytes of patients with septic shock
por: Barth, E, et al.
Publicado: (2000)

Click Chemistry-Generated Auristatin F–Linker–Benzylguanine for a SNAP-Tag-Based Recombinant Antibody–Drug Conjugate Demonstrating Selective Cytotoxicity toward EGFR-Overexpressing Tumor Cells
por: Huysamen, Allan M., et al.
Publicado: (2023)

Co-Infection with Mycobacterium tuberculosis Impairs HIV-Specific CD8+ and CD4+ T Cell Functionality
por: Chetty, Shivan, et al.
Publicado: (2015)

Monocytic and neutrophilic CD11b and CD64 in severe sepsis
por: Jämsä, J, et al.
Publicado: (2012)

CD81 is a novel immunotherapeutic target for B cell lymphoma
por: Vences-Catalán, Felipe, et al.
Publicado: (2019)

CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment
por: Seyfrid, Mathieu, et al.
Publicado: (2022)

CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma
por: Freile, Jimena Álvarez, et al.
Publicado: (2022)

Significance of CD80 as a Prognostic and Immunotherapeutic Biomarker in Lung Adenocarcinoma
por: Feng, Wei, et al.
Publicado: (2023)

The Effect of Target Sex, Sexual Dimorphism, and Facial Attractiveness on Perceptions of Target Attractiveness and Trustworthiness
por: Hu, Yuanyan, et al.
Publicado: (2018)

Immunotherapeutic potential of CD4 and CD8 single-positive T cells in thymic epithelial tumors
por: Yamamoto, Yoko, et al.
Publicado: (2020)

Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents
por: Velasco-de Andrés, María, et al.
Publicado: (2020)

IFNγ Enhances CD64-Potentiated Phagocytosis of Treponema pallidum Opsonized with Human Syphilitic Serum by Human Macrophages
por: Hawley, Kelly L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7nnsii5f24pr1696oman8iv5rv